Atossa Therapeutics Inc ATOS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 12/03/21 EST
2.01quote price arrow up+0.08 (+4.15%)
Volume
73,514
Close
1.93quote price arrow down-0.17 (-8.10%)
Volume
5,744,074
52 week range
0.81 - 9.80
Loading...
  • Open2.09
  • Day High2.10
  • Day Low1.90
  • Prev Close2.10
  • 52 Week High9.80
  • 52 Week High Date06/25/21
  • 52 Week Low0.81
  • 52 Week Low Date12/17/20

Key Stats

  • Market Cap244.38M
  • Shares Out126.62M
  • 10 Day Average Volume3.49M
  • Dividend-
  • Dividend Yield-
  • Beta2.22
  • YTD % Change103.16

KEY STATS

  • Open2.09
  • Day High2.10
  • Day Low1.90
  • Prev Close2.10
  • 52 Week High9.80
  • 52 Week High Date06/25/21
  • 52 Week Low0.81
  • 52 Week Low Date12/17/20
  • Market Cap244.38M
  • Shares Out126.62M
  • 10 Day Average Volume3.49M
  • Dividend-
  • Dividend Yield-
  • Beta2.22
  • YTD % Change103.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.85
  • P/E (TTM)-2.26
  • Fwd P/E (NTM)-9.19
  • EBITDA (TTM)-18.232M
  • ROE (TTM)-34.46%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/28/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Atossa Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Atossa Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing medicines for breast cancer and Covid-19. Its Covid-19 drugs under development, including the AT-H201 program, is for severely ill patients on ventilators, and AT-301 COVID-19 is a nasal spray. Its nasal spray formulation AT-301 is being designed to contain ingredients that can potentially block SARS-CoV-2 viral entry gene proteins in nasal epithelial...
Steven Quay M.D., Ph.D.
Chairman
Kyle Guse Esq., J.D.
Chief Financial Officer
Address
107 Spring St
Seattle, WA
98104-1005
United States

Top Peers

SYMBOLLASTCHG%CHG
APLT
Applied Therapeutics Inc
10.67-0.71-6.24%
PDSB
PDS Biotechnology Corp
8.42-0.68-7.47%
ZIOP
ZIOPHARM Oncology Inc
1.22-0.10-7.58%
CLNN
Clene Inc.
5.30+0.18+3.52%
ETNB
89Bio Inc
12.84-0.44-3.31%